0

    539206

    GVBL

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    GENOMIC VALLEY BIOTECH LIMITED Share Price Today

    Investment Returns

    Over 1 Month 10.13% Over 3 Months 20.45% Over 6 Months 22.61% Over 1 Year -38.38%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    GENOMIC VALLEY BIOTECH LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 9.30
    • P/E Ratio (TTM) 303.90
    • Beta 0.46
    • Book Value / share 12.84
    • Return on equity 9.69%
    • EPS (TTM) 0.10
    • Dividend yield [-]%
    • Net profit/quarter (Cr) -0.01
    info icon alternate text

    GENOMIC VALLEY BIOTECH LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.04
    Operating Expense 0.04
    Net Profit -0.01
    Net Profit Margin (%) -25.00
    Earnings Per Share (EPS) -0.03
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 0.05
    Operating Expense 0.04
    Net Profit 0.01
    Net Profit Margin (%) 20.00
    Earnings Per Share (EPS) 0.03
    EBITDA 0.01
    Effective Tax Rate (%) 0.00
    Particulars SEP 2025 (Values in Cr)
    Revenue 0.09
    Operating Expense 0.09
    Net Profit 0.00
    Net Profit Margin (%) 0.00
    Earnings Per Share (EPS) 0.01
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars JUN 2025 (Values in Cr)
    Revenue 0.09
    Operating Expense 0.07
    Net Profit 0.02
    Net Profit Margin (%) 22.22
    Earnings Per Share (EPS) 0.08
    EBITDA 0.02
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.26
    Operating Expense 0.26
    Net Profit -0.08
    Net Profit Margin (%) -30.76
    Earnings Per Share (EPS) -0.27
    EBITDA 0.00
    Effective Tax Rate (%) 0.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 0.27
    Operating Expense 0.23
    Net Profit 0.03
    Net Profit Margin (%) 11.11
    Earnings Per Share (EPS) 0.10
    EBITDA 0.04
    Effective Tax Rate (%) 25.00
    Particulars MAR 2025 (Values in Cr)
    Revenue 0.84
    Operating Expense 0.41
    Net Profit 0.36
    Net Profit Margin (%) 42.85
    Earnings Per Share (EPS) 1.17
    EBITDA 0.44
    Effective Tax Rate (%) 20.45
    Particulars MAR 2024 (Values in Cr)
    Revenue 0.17
    Operating Expense 0.15
    Net Profit 0.02
    Net Profit Margin (%) 11.76
    Earnings Per Share (EPS) 0.05
    EBITDA 0.02
    Effective Tax Rate (%) 0.00
    Particulars MAR 2023 (Values in Cr)
    Revenue 2.72
    Operating Expense 1.85
    Net Profit 0.65
    Net Profit Margin (%) 23.89
    Earnings Per Share (EPS) 2.12
    EBITDA 0.66
    Effective Tax Rate (%) 0.00
    Particulars MAR 2022 (Values in Cr)
    Revenue 0.07
    Operating Expense 0.57
    Net Profit -0.01
    Net Profit Margin (%) -14.28
    Earnings Per Share (EPS) -0.03
    EBITDA 0.12
    Effective Tax Rate (%) 0.00
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 12.76
    ROE % 9.69
    ROCE % 12.11
    Total Debt to Total Equity 0.00
    EBITDA Margin 52.38
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 11.60
    ROE % 0.57
    ROCE % 0.57
    Total Debt to Total Equity 0.00
    EBITDA Margin 11.76
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 11.55
    ROE % 28.48
    ROCE % 25.67
    Total Debt to Total Equity 0.00
    EBITDA Margin 33.82
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 9.42
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.21
    EBITDA Margin -428.57
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 14.69
    ROE % 0.00
    ROCE % 0.00
    Total Debt to Total Equity 0.32
    EBITDA Margin -61.90
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 4.35
    Total Liabilities 4.35
    Total Equity 3.89
    Share Outstanding 0
    Price to Book Ratio 4.59
    Return on Assets (%) 8.17
    Return on Capital (%) 9.13
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 4.33
    Total Liabilities 4.33
    Total Equity 3.54
    Share Outstanding 0
    Price to Book Ratio 2.99
    Return on Assets (%) 0.35
    Return on Capital (%) 0.43
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.04
    Total Assets 4.42
    Total Liabilities 4.42
    Total Equity 3.52
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 14.66
    Return on Capital (%) 18.38
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 0.00
    Total Assets 3.79
    Total Liabilities 3.79
    Total Equity 2.87
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -0.24
    Return on Capital (%) -0.32
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.01
    Total Assets 7.61
    Total Liabilities 7.61
    Total Equity 4.48
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) -7.33
    Return on Capital (%) -9.26
    Particulars MAR 2025 (Values in Cr)
    Net Income 0.44
    Cash from Operations 0.11
    Cash from Investing 0.01
    Cash from Financing 0.00
    Net change in Cash 0.03
    Free Cash Flow 0.12
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.01
    Cash from Operations -0.02
    Cash from Investing -0.01
    Cash from Financing 0.00
    Net change in Cash -0.03
    Free Cash Flow -0.02
    Particulars MAR 2023 (Values in Cr)
    Net Income 0.91
    Cash from Operations -0.77
    Cash from Investing 1.52
    Cash from Financing -0.70
    Net change in Cash 0.03
    Free Cash Flow -0.77
    Particulars MAR 2022 (Values in Cr)
    Net Income -0.42
    Cash from Operations -2.12
    Cash from Investing 3.66
    Cash from Financing -1.54
    Net change in Cash 0.00
    Free Cash Flow -2.12
    Particulars MAR 2021 (Values in Cr)
    Net Income -0.50
    Cash from Operations 1.48
    Cash from Investing -1.57
    Cash from Financing 0.06
    Net change in Cash -0.02
    Free Cash Flow 3.06
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    KESORAM INDUSTRIES LTD 10.18 0.00 0.85 316.30 4.58 14.31
    Max Financial Services Limited 1576.75 0.00 10.30 54415.97 1408.05 1891.35
    MODI RUBBER LTD. 132.09 0.00 0.62 330.75 98.41 167.50
    THOMAS COOK (INDIA) LTD. 102.40 21.60 2.46 4816.70 86.15 188.45
    RAIN INDUSTRIES LIMITED 204.10 22.75 0.92 6864.90 99.85 214.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    KESORAM INDUSTRIES LTD 10.18 8.93 0.91 316.30 4.58 14.31
    MPIL CORPORATION LTD. 548.15 0.00 3.39 31.24 324.70 639.20
    Max Financial Services Limited 1576.75 0.00 8.06 54415.97 1408.05 1891.35
    MODI RUBBER LTD. 132.09 0.00 1.47 330.75 98.41 167.50

    GENOMIC VALLEY BIOTECH LIMITED shareholding pattern

    Holding
    53.93%
    46.06%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    GENOMIC VALLEY BIOTECH LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    29.93 3.20 redarrow
    red-green-graph indicator
    9 Bearish
    7 Bullish
    • 5 Days 30.00
    • 26 Days 29.70
    • 10 Days 0.00
    • 50 Days 28.70
    • 12 Days 30.30
    • 100 Days 28.30
    • 20 Days 30.00
    • 200 Days 31.90
    29.10 PIVOT
    First Support 28.90 First Resistance 29.21 Second Support 28.79 Second Resistance 29.41 Third Support 28.59 Third Resistance 29.52
    RSI 47.76 ADX 25.79 MACD 0.67 Williams % R -81.36 Commodity Channel Index (CCI) -45.67
    Date 2026-07-09 Week 555.00 Same Day 51.00 Month 1120.00
    1 Year 0.46 3 Year 0.37
    Over 1 Month
    10.13% down
    Over 1 Year
    -38.38% down
    Over 3 Months
    20.45% down
    Over 3 Years
    13.17% down
    Over 6 Months
    22.61% down
    Over 5 Years
    6.96% down

    GENOMIC VALLEY BIOTECH LIMITED Corporate Actions

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Genomic Valley Biotech Ltd?

    Answer Field

    Genomic Valley Biotech Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 29.93 as on Jul 10 2026 03:15 PM.

    What is the Market Cap of Genomic Valley Biotech Ltd Share?

    Answer Field

    The market cap of Genomic Valley Biotech Ltd for NSE ₹ 0.00 & for BSE ₹ 9.30 as on Jul 10 2026 03:15 PM.

    What is the 52 Week High and Low of Genomic Valley Biotech Ltd?

    Answer Field

    The 52 Week High and Low of Genomic Valley Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 53.49 and ₹ 20.10.

    What is 1 year return for Genomic Valley Biotech Ltd?

    Answer Field

    The 1 year returns on the stock has been -38.38%.

    What is the P/E Ratio of Genomic Valley Biotech Ltd Share?

    Answer Field

    As on Jul 10 2026 03:15 PM the price-to-earnings (PE) ratio for Genomic Valley Biotech Ltd share is 303.90.

    What is the PB ratio of Genomic Valley Biotech Ltd Share?

    Answer Field

    As on Jul 10 2026 03:15 PM, the price-to-book (PB) ratio for Genomic Valley Biotech Ltd share is 12.84.

    How to Buy Genomic Valley Biotech Ltd Share?

    Answer Field

    You can trade in Genomic Valley Biotech Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Genomic Valley Biotech Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Genomic Valley Biotech Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Genomic Valley Biotech Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |